A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SR / strontium ranelate

[Related PubMed/MEDLINE]
Total Number of Papers: 79
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SR  (>> Co-occurring Abbreviation)
Long Form:   strontium ranelate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Effect of strontium ranelate on rabbits with steroid-induced osteonecrosis of femoral head through TGF-beta1/BMP2 pathway. BMP2, ELISA, HE, mRNA, RT-PCR, SIONFH, TGF-beta1, VEGF
2020 Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance. EMA, PY, RMM
2019 Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy. AF, BPs, CCV, CI, OR
2019 Multiple and Promising Applications of Strontium (Sr)-Containing Bioactive Glasses in Bone Tissue Engineering. BGs
2019 Prevention of ovariectomy-induced osteoporosis in rats : Comparative study of zoledronic acid, parathyroid hormone (1-34) and strontium ranelate. ZA
2019 The Prevention and Therapy of Osteoporosis: A Review on Emerging Trends from Hormonal Therapy to Synthetic Drugs to Plant-Based Bioactives. SERMs
2018 Combined effect of parathyroid hormone and strontium ranelate on bone healing in ovariectomized rats. PTH
2018 Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. SERMs, SHR
2018 Effect of Strontium Ranelate on the Muscle and Vertebrae of Ovariectomized Rats. ---
10  2018 Effects of strontium ranelate on wear particle‑induced aseptic loosening in female ovariectomized mice. ALN, OPG, RANKL
11  2018 Local delivery of strontium ranelate promotes regeneration of critical size bone defects filled with collagen sponge. BS, BV, C50SR, C5SR, Tb.N, Tb.Sp, Tb.Th
12  2018 Osteoinductivity and Antibacterial Properties of Strontium Ranelate-Loaded Poly(Lactic-co-Glycolic Acid) Microspheres With Assembled Silver and Hydroxyapatite Nanoparticles. HANPs, PLGA
13  2018 Strontium Ranelate Combined with Insulin Is as Beneficial as Insulin Alone in Treatment of Fracture Healing in Ovariectomized Diabetic Rats. DOFI, T2DM
14  2018 Strontium ranelate inhibits wear particle-induced aseptic loosening in mice. KO, OPG, RANKL, WT
15  2018 Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-kappaB ligand invivo. OPG, RANKL
16  2017 A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate. AFFs, TPTD
17  2017 Advanced glycation end products and strontium ranelate promote osteogenic differentiation of vascular smooth muscle cells invitro: Preventive role of vitamin D. AGE, VSMC
18  2017 Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis. BMD, PTH, WBVV
19  2017 Investigating the Effects of Systemically Administered Strontium Ranelate on Alveolar Bone Loss Histomorphometrically and Histopathologically on Experimental Periodontitis in Rats. ABL, BALP, IL, OPG, RANKL
20  2017 Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis. BMD, OA, SMI, Tb.Sp, Tb.Th
21  2016 A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation. CMV, DRESS, EBV, HHV
22  2016 Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. OPG, PO
23  2016 Sequential administration of alendronate and strontium ranelate: histomorphometry and bone biomechanics in ovariectomized animals. ALN, VEH
24  2016 Strontium Ranelate Effect on the Repair of Bone Defects and Molecular Components of the Cortical Bone of Rats. Ca, EDS, FTIR, Tb.Th
25  2016 Strontium ranelate increases osteoblast activity. FN, OPN
26  2016 The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats. WBV
27  2015 In Vitro Effects of Strontium on Proliferation and Osteoinduction of Human Preadipocytes. ALP, HA
28  2015 Strontium ranelate analgesia in arthritis models is associated to decreased cytokine release and opioid-dependent mechanisms. CINC, OA, Zy
29  2015 The Impact of Strontium Ranelate on Metaphyseal Bone Healing in Ovariectomized Rats. BMD
30  2015 The potential role of strontium ranelate in treating particle-induced osteolysis. UHMWPE
31  2014 Consumption of osteoanabolic drugs and strontium ranelate in the treatment of osteoporosis in the Czech Republic in 2005-2011. CZ, iPTH, TRPD
32  2014 Osteoblast response to titanium surfaces coated with strontium ranelate-loaded chitosan film. ALP, BMP-2, FTIR, ICP-OES, POBs, SEM, XRD
33  2014 Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo. muCT
34  2014 Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn(2+) and Mg (2+). ALP
35  2014 Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates. BMD
36  2014 What about strontium ranelate in osteoarthritis? Doubts and securities. DMOADs, OA
37  2014 [Research progress of effects of strontium ranelate on osteoarthritis]. ---
38  2013 Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. PBMC, PBMCs
39  2013 Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats. ALN, BMD
40  2013 Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism. Ca ex, iCa, PHPT, PO, PTH
41  2013 Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration. AFF, BP, LS, TRP
42  2013 Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model. MMT, OA, TMD
43  2013 Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. ALN, Sham, ZOL
44  2013 [Effects of strontium ranelate on mononuclear leukocyte culture]. ---
45  2013 [Strontium ranelate promotes osteogenic differentiation of rat bone mesenchymal stem cells through bone morphogenetic protein-2/Smad signaling pathway]. ALP, BMP-2, BMSCs
46  2012 Effects of strontium ranelate on osseointegration of titanium implant in osteoporotic rats. micro-CT, OCN, TRAP
47  2012 Strontium ranelate treatment improves oxidative damage in osteoporotic rat model. CAT, GSH-Px, MDA, SOD
48  2011 Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats. BMC, LV, TPTD
49  2011 The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial. QOL
50  2011 Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment. ---
51  2011 Use of strontium as a treatment method for osteoporosis. SOTI, TROPOS
52  2011 [Strontium ranelate promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells by increasing bone morphogenetic protein-7 expression]. BMP-7, BMSCs
53  2010 Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure. BP, HA
54  2010 Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures. MPR
55  2010 Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates. ---
56  2010 Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. HA
57  2010 Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. ---
58  2009 Continuous broad protection against osteoporotic fractures with strontium ranelate. QUALIOST, SOTI, TROPOS
59  2009 Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide. BMD, BSAP, DXA
60  2009 Effects of strontium ranelate, raloxifene and misoprostol on bone mineral density in ovariectomized rats. BMD
61  2009 No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial. ALP, P1NP
62  2009 Osteoporosis: from early fracture prevention to better bone health with strontium ranelate. SOTI, TROPOS
63  2009 Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. DMP, OPG
64  2008 Cytotoxicity analysis of strontium ranelate on cultured human periodontal ligament fibroblasts: a preliminary report. ---
65  2008 Effect of strontium ranelate on hydrogen peroxide-induced apoptosis of CRL-11372 cells. ---
66  2007 Effect of strontium ranelate on fracture healing in rat tibia. ---
67  2007 Improvement in bone strength parameters. The role of strontium ranelate. ---
68  2007 Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. BMD
69  2007 Serum osteoprotegerin concentration with strontium ranelate treatment for postmenopausal osteoporosis: an open, prospective study. PMO, RANK
70  2007 The correction of BMD measurements for bone strontium content. BMD, BSC, CaHA, DXA, SrHA
71  2006 Strontium ranelate: a novel treatment in postmenopausal osteoporosis. SOTI, TROPOS
72  2005 [Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]. ---
73  2004 Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. ALP
74  2003 Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate. ---
75  2003 Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies. BMD
76  2003 The mineralization of bone tissue: a forgotten dimension in osteoporosis research. ---
77  2002 Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. ---
78  2002 Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. BMD
79  2002 Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. BMD